The value of radiomics based on 2-[18 F]FDG PET/CT in predicting WHO/ISUP grade of clear cell renal cell carcinoma

被引:1
作者
Han, Yun [1 ,2 ]
Wang, Guanyun [2 ,3 ]
Zhang, Jingfeng [1 ,2 ]
Pan, Yue [2 ]
Cui, Jianbo [1 ,2 ]
Li, Can [2 ]
Wang, Yanmei [4 ]
Xu, Xiaodan [2 ]
Xu, Baixuan [1 ,2 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Grad Sch, 28 Fuxing Rd, Beijing 100853, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Nucl Med, 28 Fuxing Rd, Beijing 100853, Peoples R China
[3] Capital Med Univ, Beijing Friendship Hosp, Nucl Med Dept, 95 Yongan Rd, Beijing 100050, Peoples R China
[4] GE Healthcare China, Shanghai, Peoples R China
来源
EJNMMI RESEARCH | 2024年 / 14卷 / 01期
关键词
PET; Clear cell renal cell carcinoma; Radiomics; World Health Organization/The International Society of Urological Pathology (WHO/ISUP) grade; F-18-FDG PET; MASS; BIOPSY; CANCER; HETEROGENEITY; PATHOLOGY;
D O I
10.1186/s13550-024-01182-7
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
BackgroundThe aim is to develop and validate radiomics based on 2-[18F]fluoro-D-glucose positron emission tomography/computed tomography (2-[18F]FDG PET/CT) parameters for predicting the World Health Organization/International Society of Urological Pathology (WHO/ISUP) grade of clear cell renal cell carcinoma (ccRCC).MethodsA total of 209 patients with 214 lesions, who underwent 2-[18F]FDG PET/CT scans between December 2016 to December 2023, were included in our study. All ccRCC lesions were categorized into low grade (WHO/ISUP grade I-II) and high grade (WHO/ISUP grade III-IV). The lesions were allocated into a training group and a testing group in a ratio of 7:3. The radiomics features were extracted by a serious of maximum standardized uptake value (SUVmax) thresholds (0,2.5%,25%,40%) with the utilization of the minimum redundancy and maximum relevance (mRMR) and least absolute shrinkage and selection operator (LASSO) regression algorithm. The clinical, radiomics and combined models were constructed. The receiver operating characteristic (ROC) curve, decision curve and calibration curves were plotted to assess the predicting performance.ResultsThe area under curve (AUC) of PET-0, PET-2.5%, PET-25%, PET-40% model in the training group were 0.881(95% CI: 0.822-0.940),0.883(95% CI: 0.825-0.942),0.889(95% CI: 0.831-0.946),0.887(95% CI: 0.826-0.948); and 0.878(95% CI: 0.777-0.978),0.876(95% CI: 0.776-0.977),0.871(95% CI: 0.769-0.972),0.882(95% CI: 0.786-0.979) in the testing group. Due to perfect prediction and verification performance, the volume of interest (VOI) from PET images with SUVmax threshold of 40% were selected to construct the radiomics model and combined model. The AUC of the clinical model and radiomics model was 0.859 (sensitivity = 0.846, specificity = 0.747) and 0.909 (sensitivity = 0.808, specificity = 0.751) in the training group, respectively; 0.882 (sensitivity = 0.857, specificity = 0.857) and 0.901 (sensitivity = 0.905, specificity = 0.833) in the testing group, respectively. In combined models, the AUC was 0.916, the sensitivity was 0.923 and the specificity was 0.808 in the training group; the AUC was 0.916, the sensitivity was 0.881 and the specificity was 0.792 in the training group.ConclusionRadiomics based on 2-[18F]FDG PET/CT can be helpful to predict WHO/ISUP grade of ccRCC.
引用
收藏
页数:12
相关论文
共 50 条
[21]   Multiparametric MRI Radiomic Model for Preoperative Predicting WHO/ISUP Nuclear Grade of Clear Cell Renal Cell Carcinoma [J].
Li, Qiong ;
Liu, Yu-jia ;
Dong, Di ;
Bai, Xu ;
Huang, Qing-bo ;
Guo, Ai-tao ;
Ye, Hui-yi ;
Tian, Jie ;
Wang, Hai-yi .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2020, 52 (05) :1557-1566
[22]   Machine learning-based multiparametric MRI radiomics nomogram for predicting WHO/ISUP nuclear grading of clear cell renal cell carcinoma [J].
Yang, Yunze ;
Zhang, Ziwei ;
Zhang, Hua ;
Liu, Mengtong ;
Zhang, Jianjun .
FRONTIERS IN ONCOLOGY, 2024, 14
[23]   A CT-based deep learning model for predicting the nuclear grade of clear cell renal cell carcinoma [J].
Lin, Fan ;
Ma, Changyi ;
Xu, Jinpeng ;
Lei, Yi ;
Li, Qing ;
Lan, Yong ;
Sun, Ming ;
Long, Wansheng ;
Cui, Enming .
EUROPEAN JOURNAL OF RADIOLOGY, 2020, 129
[24]   Three Primary Carcinomas on 18F-FDG PET/CT: Intrahepatic Cholangiocarcinoma, Papillary Renal Cell Carcinoma, and Clear Cell Renal Cell Carcinoma [J].
Wu, Dayong ;
Hu, Yujing ;
Wei, Qiang ;
Tian, Congna ;
Bian, Yanzhu .
CLINICAL NUCLEAR MEDICINE, 2018, 43 (06) :428-430
[25]   Value of [68Ga]Ga-NYM046 PET/CT, in Comparison with 18 F-FDG PET/CT, for Diagnosis of Clear Cell Renal Cell Carcinoma [J].
Lou, Kequan ;
Wang, Jialiang ;
He, Huihui ;
Wang, Yanjuan ;
Mi, Yuanyuan ;
Li, Wenjin ;
Chen, Liping ;
Zhang, Yu ;
Mao, Yong ;
Lin, Jianguo ;
Fu, Haitian ;
Yu, Chunjing .
JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (12) :1884-1890
[26]   Development and Validation of an 18 F-FDG PET/CT-based Radiomics Nomogram for Predicting the Prognosis of Patients with Esophageal Squamous Cell Carcinoma [J].
Huang, Jiahui ;
Li, Tiannv ;
Tang, Lijun ;
Hu, Yuxiao ;
Hu, Yao ;
Gu, Yingying .
ACADEMIC RADIOLOGY, 2024, 31 (12) :5066-5077
[27]   Association of sex-specific abdominal adipose tissue with WHO/ISUP grade in clear cell renal cell carcinoma [J].
Li, Shichao ;
Liao, Zhouyan ;
He, Kangwen ;
Shen, Yaqi ;
Hu, Shan ;
Li, Zhen .
INSIGHTS INTO IMAGING, 2023, 14 (01)
[28]   Head-to-head comparison of [68Ga]Ga-P16-093 and 2-[18F]FDG PET/CT in patients with clear cell renal cell carcinoma: a pilot study [J].
Wang, Guochang ;
Li, Linlin ;
Wang, Jiarou ;
Zang, Jie ;
Chen, Jingci ;
Xiao, Yu ;
Fan, Xinrong ;
Zhu, Lin ;
Kung, Hank F. F. ;
Zhu, Zhaohui .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (05) :1499-1509
[29]   Predictive value of computed tomography radiomics combined with traditional imaging features in WHO/ISUP grading of clear cell renal carcinoma [J].
Feng, Yu-Ning ;
Zhu, Yu-Hui ;
Feng, Xiao-Rong ;
Wu, Ju-Fang ;
Wei, Di ;
Huang, Guang-Di ;
Jiang, Yun-Dan .
INTERNATIONAL JOURNAL OF IMAGING SYSTEMS AND TECHNOLOGY, 2024, 34 (03)
[30]   Clinical value of 18F-FDG-PET/CT in staging cutaneous squamous cell carcinoma [J].
Mahajan, Sonia ;
Barker, Christopher A. ;
Singh, Bhuvanesh ;
Pandit-Taskar, Neeta .
NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (07) :744-751